Subscribe Now Subscribe Today
Science Alert
 
   
 
    Publisher: Academic Journals Inc., USA
   
  Trends in Medical Research publishes original, peer-reviewed research work in all areas of medical and applied health sciences. Scope of the journal includes: Medicine, dentistry, nursing and allied health sciences, pharmacy, pathology, anatomy, surgery, physiology, pharmacology and toxicology.

Trends in Medical Research now accepting new submissions. Submit your best paper via online submission system.

  Editor-in-Chief:  Nima Rezaei
 
 
Alam, S.M., M. Rajendran, S. Ouyang, S. Veeramani, L. Zhang and M.F. Lin, 2008. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocr. Relat. Cancer, 16: 1-16.
CrossRef  |  
Chuang, T.D., S.J. Chen, F.F. Lin, S. Veeramani and S. Kumar et al., 2010. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. J. Biol. Chem., 285: 23598-23606.
CrossRef  |  
Rajendran, M., P. Thomes, L. Zhang, S. Veeramani and M.F. Lin, 2010. p66Shc: A longevity redox protein in human prostate cancer progression and metastasis: p66Shc in cancer progression and metastasis. Cancer Metastasis Rev., 29: 207-222.
CrossRef  |  PubMed  |  Direct Link  |  
Veeramani, S., M.S. Lee and and M.F. Lin, 2009. Revisiting histidine-dependent acid phosphatases: A distinct group of tyrosine phosphatases. Trends Biochem. Sci., 34: 273-278.
PubMed  |  
Veeramani, S., S.Y. Wang, C. Dahle, S. Blackwell and L. Jacobus et al., 2011. Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism. Blood, 118: 3347-3349.
PubMed  |  Direct Link  |  
Veeramani, S., T. Igawa, T.C. Yuan, F.F. Lin and M.S. Lee et al., 2005. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. Oncogene, 24: 7203-7212.
Direct Link  |  
Veeramani, S., T.C. Yuan, F.F. Lin and M.F. Lin, 2008. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene, 27: 5057-5068.
PubMed  |  
Veeramani, S., T.C. Yuan, S.J. Chen, F.F. Lin and J.E. Petersen et al., 2005. Cellular prostatic acid phosphatase: A protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. Endocr. Relat. Cancer, 12: 805-822.
CrossRef  |  PubMed  |  Direct Link  |  
Veeramani, S., Y.W. Chou, F.C. Lin, S. Muniyan and F.F. Lin et al., 2012. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol. Med., 53: 95-108.
PubMed  |  Direct Link  |  
Wang, S.Y., S. Veeramani, E. Racila, J. Cagley and D.C. Fritzinger et al., 2009. Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model. Blood, 114: 5322-5330.
PubMed  |  
Yuan, T.C., F.F. Lin, S. Veeramani, S.J. Chen, H.S. Earp 3rd and M.F. Lin, 2007. ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene, 26: 7552-7559.
PubMed  |  
Yuan, T.C., S. Veeramani and M.F. Lin, 2007. Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr. Relat. Cancer, 14: 531-547.
PubMed  |  
Yuan, T.C., S. Veeramani, F.F. Lin, D. Kondrikou and S. Zelivianski et al., 2006. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr. Relat. Cancer, 13: 151-167.
PubMed  |